Trident Lifeline

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE0MKA01014
NSEID:
BSEID: 543616

INR

248.15

-12.85 (-4.92%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 2400

Click here to access the older version

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.4 k (185.71%) Volume

Shareholding (Dec 2024)

FII

6.09%

Held by 3 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

62.99%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Stock is technically in a Mildly Bearish range

The technical trend has deteriorated from Sideways on 09-Apr-25 and has generated -4.92% returns since then
The stocks Bollinger Band and KST technical factors are also Bearish

With ROCE of 9.9, it has a Very Expensive valuation with a 5.1 Enterprise value to Capital Employed

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Drugs

Market cap

INR 285 Cr (Micro Cap)

P/E

29.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.24

Return on Equity

12.21%

Price to Book

6.01

Revenue and Profits (1 Year):

Net Sales:

12 Cr

(Quarterly Results - Dec 2024)

Net Profit:

3 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

6 Months

-12.93%

1 Year

50.39%

2 Years

64.34%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Trident Lifeline for the last several years.

Risk Adjusted Returns v/s Sensex

Returns Beta

Beta has not been calculated since enough price history is not available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

43.10%

EBIT Growth (5y)

57.52%

EBIT to Interest (avg)

6.22

Debt to EBITDA (avg)

0.99

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.07

Tax Ratio

34.30%

Dividend Payout Ratio

Pledged Shares

3.46%

Institutional Holding

6.09%

ROCE (avg)

16.34%

ROE (avg)

13.00%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

6.01

EV to EBIT

27.65

EV to EBITDA

24.03

EV to Capital Employed

5.06

EV to Sales

5.24

PEG Ratio

0.32

Dividend Yield

ROCE (Latest)

9.85%

ROE (Latest)

12.21%

Tecnicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2024

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

3.4632

Mutual Funds

Held by 0 Schemes

FIIs

Held by 3 FIIs (6.09%)

Promoter with highest holding

Hardik Jigishkumar Desai (23.5%)

Highest Public shareholder

Nav Capital Vcc - Nav Capital Emerging Star Fund (6.01%)

Individual Investors Holdings

18.9%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -23.43% vs 17.49% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -9.71% vs 34.93% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.83",
          "val2": "15.45",
          "chgp": "-23.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.08",
          "val2": "4.05",
          "chgp": "0.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.55",
          "val2": "0.50",
          "chgp": "10.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2.79",
          "val2": "3.09",
          "chgp": "-9.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.49%",
          "val2": "26.21%",
          "chgp": "8.28%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 12.28% vs 40.20% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 90.46% vs -9.00% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "29.25",
          "val2": "26.05",
          "chgp": "12.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.19",
          "val2": "4.24",
          "chgp": "69.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.99",
          "val2": "0.40",
          "chgp": "147.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.39",
          "val2": "2.83",
          "chgp": "90.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.58%",
          "val2": "16.28%",
          "chgp": "8.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 35.09% vs 18.51% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 38.64% vs 22.66% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "41.08",
          "val2": "30.41",
          "chgp": "35.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.27",
          "val2": "8.04",
          "chgp": "40.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.54",
          "val2": "0.75",
          "chgp": "105.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.18",
          "val2": "5.90",
          "chgp": "38.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.43%",
          "val2": "26.44%",
          "chgp": "0.99%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 40.83% vs 45.57% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 5.49% vs 52.15% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "44.63",
          "val2": "31.69",
          "chgp": "40.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.19",
          "val2": "6.24",
          "chgp": "31.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.47",
          "chgp": "27.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.34",
          "val2": "6.01",
          "chgp": "5.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.35%",
          "val2": "19.69%",
          "chgp": "-1.34%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ

Dec'24

Sep'24

Change(%)

Net Sales

11.83

15.45

-23.43%

Operating Profit (PBDIT) excl Other Income

4.08

4.05

0.74%

Interest

0.55

0.50

10.00%

Exceptional Items

0.00

Consolidate Net Profit

2.79

3.09

-9.71%

Operating Profit Margin (Excl OI)

34.49%

26.21%

8.28%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2024 is -23.43% vs 17.49% in Sep 2024

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -9.71% vs 34.93% in Sep 2024

All Quarterly Results

Half Yearly Results Snapshot (Consolidated) - Sep'24

Sep'24

Mar'24

Change(%)

Net Sales

29.25

26.05

12.28%

Operating Profit (PBDIT) excl Other Income

7.19

4.24

69.58%

Interest

0.99

0.40

147.50%

Exceptional Items

0.00

Consolidate Net Profit

5.39

2.83

90.46%

Operating Profit Margin (Excl OI)

24.58%

16.28%

8.30%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Sep 2024 is 12.28% vs 40.20% in Mar 2024

Consolidated Net Profit

Growth in half year ended Sep 2024 is 90.46% vs -9.00% in Mar 2024

All Half Yearly Results

Nine Monthly Results Snapshot (Consolidated) - Dec'24

Dec'24

Change(%)

Net Sales

41.08

30.41

35.09%

Operating Profit (PBDIT) excl Other Income

11.27

8.04

40.17%

Interest

1.54

0.75

105.33%

Exceptional Items

0.00

Consolidate Net Profit

8.18

5.90

38.64%

Operating Profit Margin (Excl OI)

27.43%

26.44%

0.99%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in nine months ended Dec 2024 is 35.09% vs 18.51% in Dec 2024

Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 38.64% vs 22.66% in Dec 2024

All Nine Monthly Results

Annual Results Snapshot (Consolidated) - Mar'24

Mar'24

Mar'23

Change(%)

Net Sales

44.63

31.69

40.83%

Operating Profit (PBDIT) excl Other Income

8.19

6.24

31.25%

Interest

0.60

0.47

27.66%

Exceptional Items

0.00

Consolidate Net Profit

6.34

6.01

5.49%

Operating Profit Margin (Excl OI)

18.35%

19.69%

-1.34%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2024 is 40.83% vs 45.57% in Mar 2023

Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 5.49% vs 52.15% in Mar 2023

All Annual Results

Company CV

About Trident Lifeline Ltd

Trident Lifeline Ltd

Micro Cap

Pharmaceuticals & Drugs

Trident Lifeline Limited was originally incorporated as Private Limited Company under the name "Trident Lifeline Private Limited" on January 09, 2014. Subsequently, Company converted into a Public Limited pursuant to Shareholders' Resolution on June 02, 2022 and name of Company was changed to "Trident Lifeline Limited" on June 10, 2022. The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market.

Company Coordinates

No Company Details Available